Xiaoyan Ding, PhD

Department of Vitreous-Retina
Zhongshan Ophthalmic Center
Sun Ya-Sen University
Guangdong, China



• (1993), BS (Bachelor of Medicine, equivalence to MD in US), Sun Yat-Sen University of Medical Science, Guangzhou, China
• (2006), PhD of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China
• (2003-2006), Fellow, Retina , Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China
• (1998- 2003), Resident, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China
• (2007-2008), Post-Doctorate, Research fellow, National Eye Institite, National Institute of Health Advisor, Dr. Chi-chao Chan, MD

Research Interest

Her research interest includes: Opthalmology.

Scientific Activities


• Vice-President Association of Maternal and Child Health Care Guangdong
• Committee Member Chinese Ophthalmic Electrophysiologic Association
• Committee Member Guangdong Ophthalmologist Association
• Member Chinese Ophthalmologist Association
• Member American Research of Visual and Ophthalmology
• Member American Academy of Ophthalmology


1. Yuan M, Yang Y, Shanshan Yu, et al. Posterior pole retinal abnormalities in mild asymptomatic. FEVR. IOVS. 2015.doi: 10.1167/iovs.14-15821
2. Chen S, Zhou M, Wang W, et al. Levels ofangiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes. Acta Ophthalmologica. 2014. doi: 10.1111/aos.12624
3. Lei L, Li T, Ding X. Gas tamponade combined with laser photocoagulation therapy for congenital optic disc pit maculopathy . Eye. 2014. doi:
4. Zeng J, Li J, Liu R, et al. Choroidal thickness in both eyes of patients with unilateral idiopathic macular hole. Ophthalmology. 2012; 119(11): 2328-2333. doi: 10.1016/j.ophtha.2012.06.008
5. Ding X, Li J, Zeng J, et al. Choroidal thickness in healthy Chinese subjects. Invest Ophthalmol Vis Sci. 2011; 52(13): 9555-9560. doi: 10.1167/iovs.11-8076
6. Ding X, Li J, Hu X, Yu S, Pan J, Tang S. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Retina. 2011; 31(5): 838-845. doi: 10.1097/IAE.0b013e3181f4420d
7. Ding X, Patel M, Shen D, et al. Enhanced HtrA2/Omi expression in oxidative injury to retinal pigment epithelial cells and murine models of neurodegeneration. Invest Ophthalmol Vis Sci. 2009; 50(10): 4957-4966. doi: 10.1167/iovs.09-3381
8. Ding X, Patel M, Herzlich A, Sieving PC, Chan CC. Ophthalmic pathology of Nance-Horan syndrome: case report and review of the literature. Ophthalmic Genet. 2009; 30(3): 127-135. doi: 10.1080/13816810902822021
9. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2009; 28(1): 1-18. doi: 10.1016/j.preteyeres.2008.10.001
10. Ding X, Bishop RJ, Herzlich AA, Patel M, Chan CC. Limbal stem cell deficiency arising from systemic chemotherapy with hydroxycarbamide. Cornea. 2009; 28(2): 221-223. doi: 10.1097/ICO.0b013e318183a3bd
11. Ding X, Herzlich AA, Bishop R,Tuo J, Chan CC. Ocular toxicity of fludarabine: a purine analog. Expert Rev Ophthalmol. 2008; 3(1): 97-109. doi: 10.1586/17469899.3.1.97
12. Ching-Yu, Cheng CY, Ding X, et al. New loci and coding variants confer risk for age-related macular degeneration in East Asians. Nature Communications. 2015. doi: 10.1038/ncomms7063
13. Yu X, Liang X, Ding X, et al. Releasable Encircling Band for Primary Rhegmatogenous Retinal Detachment. Ophthalmology. 2014. doi: 10.1016/j.ophtha.2014.07.028
14. Wang J, Zhou M, Zhang X, et al. Short-term effect of intravitreal ranibizumab on intraocular concentrations of VEGF-A and PEDF in neovascular glaucoma. Clin Experiment Ophthalmol. 2014. doi: 10.1111/ceo.12477
15. Zhou M, Wang W, Ding X, et al. Choroidal thickness in fellow eyes of patients with acute primary angle-closure measured by enhanced depth imaging spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013; 54(3): 1971-1978. doi: 10.1167/iovs.12-11090
16. Zhou M, Chen S, Wang W, et al. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab. Invest Ophthalmol Vis Sci. 2013; 54(6): 3874-3879. doi: 10.1167/iovs.12-11507
17. Wang W, Zhou M, Huang W, Chen S, Ding X, Zhang X. Does acute primary angle-closure cause an increased choroidal thickness?. Invest Ophthalmol Vis Sci . 2013; 54(5): 3538-3545. doi: 10.1167/iovs.13-11728
18. Huang W, Wang W, Zhou M, et al. Peripapillary choroidal thickness in healthy Chinese subjects. BMC Ophthalmol. 2013; 13: 23. doi: 10.1186/1471-2415-13-23
19. Yu H, Li T, Luo Y, et al. Long-term outcomes of vitrectomy for progressive X-linked retinoschisis. Am J Ophthalmol. 2012; 154(2): 394-402 e392. doi: 10.1016/j.ajo.2012.02.005
20. Hu A, Luo Y, Li T, et al. Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes. Graefes Arch Clin Exp Ophthalmol. 2012; 250(7): 957-962. doi: 10.1007/s00417-011-1855-x
21. Bishop RJ, Ding X, Heller CK, et al. Rapid vision loss associated with fludarabine administration. Retina. 2010; 30(8): 1272-1277. doi: 10.1097/IAE.0b013e3181d20589
22. Clarke GL, Ding X, Gangaputra S, et al. Recalcitrant granulomatous sclerouveitis in a patient with granulomatous ANCA-associated vasculitis. Ocul Immunol Inflamm. 2009, 17(2): 83-87. doi: 10.1080/09273940802596500
23. Herzlich AA, Ding X, Shen D, Ross RJ, Tuo J, Chan CC. Peroxisome Proliferator-Activated Receptor Expression in Murine Models and Humans with Age-related Macular Degeneration. Open Biol J. 2009; 2: 141-148. doi: 10.2174/1874196700902010141
24. Hejtmancik JF, Jiao X, Li A, et al. Mutations in KCNJ13 cause autosomal-dominant snowflake vitreoretinal degeneration. Am J Hum Genet. 2008; 82(1): 174-180. doi: 10.1016/j.ajhg.2007.08.002
25. Liu R, Yang Y, Wei C, Li Z, Ding X. The age-related maculopathy susceptibility 2 polymorphism andpolypoidal choroidal vasculopathy. a systemic review and meta-analysis. Chin J Ocul Fundus Dis. 2014; 30(3): 299-303.
26. Wei C, Liu R, Li J, Yang Y, Ding X. Spectral domain optical coherence tomography characteristics ofpolpoidal choroidal vasculopathy and its correlation between vision outcomes. Chin J Ocul Fundus Dis . 2014; 30(3): 241-244.
27. Yang Y, Li Z, Ding X. Retinal hemorrhage in newborns. Chin J Ocul Fundus Dis. 2014; 30(1): 109-111.
28. Zeng J, Yan Y, Ding X, Liu R, Li J. Choroidal thickness after half-dose verteporfin photodynamic therapy inchronic central serous chorioretinopathy. Chin J Ophthalmol. 2013; 49(6): 490-494.
29. Zeng J, Liu R, Zhang X, et al. Relationship between gender and posterior pole choroidal thickness in normal eyes. Chin J Ophthalmol. 2012, 48(12): 1093-1096.
30. Zeng J, Liu R, Li J, Zhu X, Tang S, Ding X. Choroidal thickness in eyes of patients with idiopathic macular hole: a cross-sectional study. Chin J Pract Ophthalmol. 2012; 30(2): 123-126.
31. Ding X, Li J, Yu S, et al. Prognostic Factors for Visual Outcome after Intravitreal Bevacizumab for Macular Edema Due to Central Retinal Vein Occlusion. Journal of Sun Yat-sen University (Medical Sciences). 2012; 33(1):79-84.
32. Li J, Ding X, Zeng J, et al. Choroidal thickness of chronic central serous chorioretinopathy with spectral-domain optical coherence tomography. Chin J Ocul Fundus Dis . 2012; 28(4): 325-328.
33. Liu R, Ding . PCV and wAMD, Same or different?. Chin J Ocul Fundus Dis. 2012, 28(5): 533-539.
34. 35. Liu R, Li J, Zeng J, et al. Compare neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in age at diagnosis, gender and disease latrtallty. Chin J Ocul Fundus Dis. 2012; 28(5): 445-448.
35. Liu R, Li J, Li T, et al. Main features of polypoidal choroidal vasculopathy byspectral-domain optical coherence tomography. Journal of Sun Yat-sen University (Medical Sciences). 2012; 33(6): 841-847.